How to switch weight loss injection providers in the UK (without losing your progress)
Switching weight loss injection providers is something more patients are doing than you might think. Whether your current service has had stock issues, costs have crept up, or you simply want better ongoing support, moving to a new prescriber doesn't mean going back to square one.
The good news is that your treatment history belongs to you. With the right preparation, you can transfer to a new UK provider at your current dose, without restarting the dose escalation schedule from the lowest dose.
This guide covers exactly what to prepare, what to expect from a new provider, and how to time the switch so you don't miss a dose.
Why patients switch weight loss injection providers
Understanding your reason for switching matters, because it shapes what to look for in a new provider. The most common reasons patients make the move are:
- Supply issues: stock availability for weight loss pens has been inconsistent across UK private providers in the past, particularly at higher doses. If your current service can't reliably fulfil your prescription, that's a clinically significant problem.
- Cost: monthly pricing for private weight loss treatment varies considerably across the UK market. Patients who started with one provider often find better value elsewhere once they're established on a stable dose.
- Lack of ongoing support: some services issue a prescription and little else. If you're not getting monthly check-ins, clinical oversight, or access to a prescribing pharmacist when you have questions, you're not getting the standard of care you should expect.
- Poor communication: delays in prescription approvals, no response to queries, or no clear escalation route are all valid reasons to move on.
Whatever your reason, switching is a legitimate and straightforward process when handled correctly.
What to gather before you switch
A new prescriber can't simply take your word for your current dose. They'll need to verify your treatment history to prescribe safely, so pull these records together before you start the process.
Your prescription history
The most important document is evidence of your current dose and how long you've been on it. This could be:
- A copy of your most recent prescription (many online providers send this by email or make it available in an app or patient portal)
- Order confirmation emails showing the dose and date of each pen supplied
- A summary from your current provider's patient records, which you're legally entitled to request under UK data protection law
Your weight and BMI records
Your new prescriber will want to confirm you still meet the eligibility criteria for Wegovy or Mounjaro.
NHS guidance sets out that both Wegovy (semaglutide) and Mounjaro (tirzepatide) are indicated for adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related health condition such as type 2 diabetes or high blood pressure.
Having a recent weight measurement ready speeds up the consultation.
Any relevant medical history
If your health has changed since you first started weight loss injections like Mounjaro or Wegovy, note it down. New medications, diagnoses, or any side effects you've experienced are all relevant to a clinical review.
Worth knowing: you don't need a referral letter or sign-off from your current provider to switch. You simply stop ordering from them and begin the consultation process with a new service.
Will I have to start at the lowest dose again?
This is the part most patients worry about: will the new provider make me start again at the lowest Mounjaro or Wegovy dose?
The short answer is no, not if you can evidence your current dose. Here's how a responsible UK prescriber such as Phlo Clinic handles an existing patient.
The clinical review
Your new provider will conduct a fresh medical questionnaire and, in most cases, a consultation with a prescribing pharmacist or clinician. This isn't a formality. It's a genuine clinical assessment that:
- Confirms your current BMI and weight-loss progress
- Reviews any side effects or tolerability issues at your current dose
- Checks for any contraindications or new health changes that make treatment unsuitable
- Verifies your dose history using the documentation you've provided
Starting at your current dose
Provided the review confirms you've been stable on your current dose for at least four weeks and have tolerated it well, a qualified prescriber can issue a prescription at that dose. You don't restart the dose escalation schedule (the gradual step-up from the lowest dose).
If you've already progressed beyond the starting dose, a new prescriber who reviews your records should prescribe at the appropriate step, not send you back to the beginning.
One exception: if there's been a significant gap in your treatment (generally four weeks or more without injections), your new prescriber may recommend stepping back down temporarily to allow your body to readjust. This is a clinical judgement call, not a blanket policy.
How to avoid a gap between pens
Timing the switch well is the most practical challenge. Wegovy and Mounjaro are both injected once a week, so a delay of even a few days in your prescription being approved and dispatched can push you past your injection day.
1. Plan the switch around your current pen
Don't wait until you've used your last dose before starting the transfer process. The best time to begin your consultation with a new provider is when you still have one to two weeks of pens remaining. This gives you a buffer while the clinical review is completed and your first order is dispatched.
2. Check delivery timelines upfront
Before committing to a new provider, confirm:
- How quickly consultations are reviewed (ideally same day or next day)
- Whether they offer tracked next-day delivery
- Whether they hold stock of your specific dose
A provider that takes five to seven days to approve a consultation and then uses standard post isn't a good fit if you're mid-treatment.
3. What to do if you do miss a dose
If a gap is unavoidable, the guidance from Novo Nordisk, Wegovy's manufacturer, is straightforward:
- If fewer than five days have passed since your missed dose, take the missed dose as soon as you remember
- If more than five days have passed, skip the missed dose entirely and take your next one on your usual day
- Never take two doses in the same week to compensate
The guidance from Eli Lilly, Mounjaro's manufacturer, differs slightly:
- If fewer than four days have passed since your missed dose, take the missed dose as soon as you remember
- If more than four days have passed, skip the missed dose and take your next one on your usual day
- Never take two doses in the same week to make up for one you've missed
A gap of up to four weeks for both drugs is generally manageable without needing to step down your dose, but always discuss this with your new prescriber during the consultation. If you've gone four weeks or more without an injection, your prescriber may suggest stepping down temporarily while your body readjusts. This is a clinical judgement based on your individual circumstances, not an automatic rule.
What to expect from the best weight loss injection providers in the UK
Not all weight loss prescription services work the same way. As the market has grown, so has the variation in clinical standards, pricing transparency, and the level of support you get after your first order.
Here's what separates a good provider from a service that simply processes orders.
Who reviews your order matters most. A qualified Independent Prescribing Pharmacist or doctor should be assessing your consultation and taking clinical responsibility for the decision. Ask any provider who reviews orders and what their qualifications are, and a legitimate service will tell you.
Ongoing care should be part of the service, not an add-on. Monthly check-ins, a route to ask questions between orders, and a review at each dose increase are all reasonable things to expect. A service that issues a prescription and then goes quiet isn't giving you the standard of care you should have.
Regulatory status is verifiable in under a minute. Any UK pharmacy supplying prescription medication must be GPhC-registered, and you can search the register yourself rather than taking a website's word for it.
Stock reliability and delivery are clinical issues, not just convenience. A weekly treatment only works if it arrives on time. Before you switch, confirm the provider holds stock at your specific dose and offers tracked delivery.
The real risk of a low-quality provider isn't just poor service. It's the clinical risk of dose errors, missed contraindication checks, or no one to call if you experience a side effect. The MHRA's updated guidance on GLP-1 medicines is clear that patients should always have access to a healthcare professional before making any changes to their treatment.
Switching to Wegovy and Mounjaro with Phlo Clinic
Phlo Clinic is a GPhC-regulated online prescribing service that has supported over 90,000 patients with medically supervised weight loss treatment across the UK. Our clinical team consists of qualified Independent Prescribing Pharmacists who review every order individually, not by algorithm.
For patients switching from another provider, the process is straightforward:
- Complete the online consultation on our Mounjaro or Wegovy treatment pages. The questionnaire is designed to capture your existing dose history and current health status.
- Upload your prescription history or note your current dose in the consultation. Our prescribing pharmacists will review this alongside your questionnaire responses.
- Receive your clinical decision typically the same day. If approved at your current dose, your first order is dispatched with free 24-hour tracked delivery.
- Ongoing monthly check-ins with our clinical team keep your treatment on track and give you direct access to a prescribing pharmacist if anything changes.
If you're also considering whether Wegovy is still the right treatment for you, our guide to Mounjaro vs Wegovy covers how the two options compare, and our GLP-1 washout period guide explains what to expect if you're considering switching between treatments rather than just providers.
Switching providers is a practical decision, not a clinical setback. The right service should make the process feel seamless, not stressful.
References
- National Institute for Health and Care Excellence (NICE). Semaglutide for managing overweight and obesity (TA875).
- National Institute for Health and Care Excellence (NICE). Tirzepatide for managing overweight and obesity (TA1026).
- Electronic Medicines Compendium. Wegovy (semaglutide) — summary of product characteristics.
- Electronic Medicines Compendium. Mounjaro (tirzepatide) — summary of product characteristics.
- Medicines and Healthcare products Regulatory Agency (MHRA). GLP-1 medicines for weight loss and diabetes: what you need to know.
- General Pharmaceutical Council. Registers — check a pharmacy.
.png)
